Vimarsana
Biggest News Aggregation in the World

Page 7 - Cell Line News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Line Today - Breaking & Trending Today

GeoVax Secures Multi-Product License for ProBioGen's - Vimarsana News

GeoVax Secures Multi-Product License for ProBioGen's

ATLANTA, GA and BERLIN, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company...

PhenomeX announces the release of SpotLight™ Human Lambda reagent for the Beacon® platform to accelerate cell line development workflows - Vimarsana News

PhenomeX announces the release of SpotLight™ Human Lambda reagent for the Beacon® platform to accelerate cell line development workflows

PhenomeX Inc., a functional cell biology company, is pleased to announce that GSK will present data on the SpotLight™ Human Lambda reagent for the Beacon® platform at the 16th annual Conference on Protein Expression in Animal Cells, which is being held in Sitges, Spain from September 24-28, 2023.

The viral vector innovations driving AAV-based therapies - Vimarsana News

The viral vector innovations driving AAV-based therapies

Discover how Cytiva is working to overcome AAV-based gene therapy manufacturing challenges

The viral vector innovations driving AAV-based therapies - Vimarsana News

The viral vector innovations driving AAV-based therapies

Discover how Cytiva is working to overcome AAV-based gene therapy manufacturing challenges

Subclonal neoantigens a key roadblock in MMRd tumor immunotherapy success - Vimarsana News

Subclonal neoantigens a key roadblock in MMRd tumor immunotherapy success

Researchers evaluated sensitivity to immune checkpoint blockade (ICB) therapy.